Regenxbio (RGNX) Other Working Capital Changes (2015 - 2025)

Regenxbio's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $3.3 million for Q4 2018.

• In Q4 2018, Other Working Capital Changes changed N/A year-over-year to $3.3 million; the TTM figure through Dec 2018 stood at $3.3 million (changed N/A YoY), while the FY2018 annual figure was $3.9 million, changed N/A from the prior year.
• Other Working Capital Changes for Q4 2018 stood at $3.3 million, up from -$35000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $39.8 million in Q1 2025, with the low at -$44.2 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is -$82000.0 (2024), against an average of $447750.0.
• Peak annual rise in Other Working Capital Changes reached 29559.26% in 2025, while the deepest fall reached 48903.45% in 2025.
• Regenxbio's Other Working Capital Changes stood at -$15000.0 in 2014, then soared by 66.67% to -$5000.0 in 2015, then plunged by 600.0% to -$35000.0 in 2016, then surged by 9622.86% to $3.3 million in 2018.
• Business Quant data shows RGNX's Other Working Capital Changes at $3.3 million in Q4 2018, -$35000.0 in Q2 2016, and -$92000.0 in Q1 2016.